Northern Michigan University Built the First Four-Year Cannabis Chemistry Degree, Then Added a Path for the Business
MARQUETTE, Mich. — Northern Michigan University did not add a cannabis elective and call it a major. In fall 2017 it opened a Bachelor of Science in Medicinal Plant Chemistry, the first four-year undergraduate degree of its kind in the United States, on a campus closer to Lake Superior than to the state capitol. The degree is still in the 2026-2027 catalog. What changed is everything around it: a second bachelor’s for cultivation rooms and dispensary floors, a stack of certificates, and a chemistry major its own faculty still describe as harder than the nickname.
The nickname arrived immediately. A public university willing to put marijuana in a lab manual was going to be called a stoner school, including by people who had not read the plan. The plan was organic chemistry, biochemistry, botany, soils, genetics, horticulture, and a year of instrumental analysis. Associate chemistry professor Brandon Canfield has said the spark came in 2016, at the American Chemical Society meeting, where he heard analytical chemists describe a workforce hole in the cannabis trade and sat through talks the drug schedule had kept out of most undergraduate programs. “I heard all about the want for analytical chemists in the cannabis sector and all sorts of intriguing talks. That was the initial spark,” he said. His other line traveled farther than the curriculum: a stereotypical stoner should not apply. “For a student to succeed, they’re going to have to be pretty devoted and motivated. This is not an uncomplicated plan. It’s a seriously intense biology and chemistry plan.”
What the 2026 catalog actually requires
The current bulletin still lists Medicinal Plant Chemistry as a Bachelor of Science: 120 credits, with 30 to 40 in general education and 83 to 92 in the major. Only chemistry courses passed at C- or better count. The chemistry core is 39 credits, from general chemistry and a medicinal plant seminar through quantitative analysis, both semesters of organic chemistry and the labs, and the analytical work that makes the degree employable. Students also take a plant kingdom course, plant physiology, statistics, soils, and a geography or environmental science course.
Then the student picks a track. The bio-analytical track, 20 to 25 credits, pushes further into chemical equilibrium, atomic spectrometry, cell and molecular biology, and genetics. That is the path for extraction, testing, and a graduate application. The entrepreneurial track is 24 credits: financial accounting, entrepreneurship, the legal environment of business, and electives that can include managerial accounting, new-venture finance, marketing, and a political science course, PS 434, titled Cannabis Law. The point of the split is that a testing lab and a licensed operator do not fail in the same way. One fails a chromatogram. The other fails an inspection.
The university’s own description, on the Medicinal Plant Chemistry page, says the program was built around mixed cohorts and a year-long capstone: plant cultivation, experimental horticulture, and natural-product analysis. Cannabis is the draw and the teaching model. It is not the only plant. Faculty have described student projects on echinacea, St. John’s wort, hops, lavender, perilla, wild-harvested species, and fungi. The early pitch on the website, that the stigma was fading faster than the classroom could be built, has aged into something plainer. The school now says it was first, and that the demand is for people who can run a method.
A small first class, then a real department
The first cohort was about a dozen students. The first graduates, in 2020, numbered 12 by the count Alexander Wilson later gave in public, after earlier campus accounts had put that pioneering class at 11. Wilson, assistant professor of chemistry and co-director of the program, briefed a Cannabis Regulatory Agency education session on March 13, 2025. He said the major had about 100 students at that point. The graduating class peaked near 50 in 2022. The class then coming up was expected to be around 30. Sixty to seventy percent of the students arrive wanting cannabis specifically. The rest, and the curriculum under all of them, are there for medicinal plants as a chemical problem that prohibition left half-described.
Wilson walked through why the last year is the degree. In CH 420 and CH 421, students grow plants — many choose cannabis, inside a campus grow room — and then analyze the material they grew. The Shimadzu instrumentation lab was already open in time for the earliest seniors. Seminars bring in working chemists. He described an evening with three alumni from testing labs on the ethical problems they had met: numbers, clients, and pressure to make a batch look legal. That is a different education from a short course on how to pass a fire inspection.
Enrollment settling from a peak is not a collapse. A major that graduates around 30 chemists, after a spike near 50, found its size. The Medicinal Plant Chemistry Club, open beyond the major, lists guest speakers and, on its public page, 145 members. The job the degree was built for still exists. Michigan’s licensed adult-use market recorded about $3.17 billion in 2025, according to monthly Cannabis Regulatory Agency figures compiled by industry trackers, down from about $3.27 billion in 2024. Medical sales in that 2025 tally were about $6.1 million. Flower prices fell hard. Labs and compliance desks still hire. A chemistry degree in the Upper Peninsula is a strange place to learn that market only if you think the plant is grown in a Detroit conference room.
The second degree, for the floor and not the beaker
Northern did not stop at the chemistry major. The cannabis programs page now describes an ecosystem of the bachelor of science, certificates, and non-credit credentials. The 2026-2027 catalog adds a Bachelor of Applied Science in Cannabis Operations and Plant-Based Wellness, 124 credits, in the College of Technology and Occupational Sciences. Graduates are aimed at cultivation, compliance, retail, and product development. The technical core runs through growing operations, dispensary work, product manufacturing, federal and state regulations, environmental controls, pest management, equity, software, and a plant-based wellness sequence. A facilities master plan dated October 31, 2025, described the same expansion: an associate degree in indoor agriculture, a bachelor’s in controlled environment agriculture, and shorter cannabis credentials beside the chemistry major.
That is a different theory of the student. Medicinal Plant Chemistry assumes you can survive organic chemistry. The applied bachelor’s assumes you will be responsible for a room, a procedure, and a regulator. When Michigan voters legalized adult use, the state created a licensed industry faster than it created people who could measure what the industry sells.
Schedule III changes the job, not the homework
On April 28, 2026, AG Order 6754-2026 placed two categories of marijuana in Schedule III: FDA-approved drug products that contain it, and marijuana covered by a qualifying state medical license. Adult-use marijuana stayed in Schedule I. A DEA hearing on whether the rest should follow ran through summer 2026. As of late September, the administrative law judge had not published a recommended decision. For a student in Marquette the split is practical. Work inside a state medical supply chain is now Schedule III, with a federal registration structure that did not exist when the first class enrolled. Work on adult-use product is still, under federal law, next to Schedule I. The chromatograph does not care. The compliance binder does.
The university has been careful, in its current copy, not to pretend the degree is a marijuana license. It says the training reaches herbal extracts, natural products, food, and laboratory standards, and that cannabis is the industry most of the students came to enter. That is the right size of the claim. The federal government spent years holding a patent on cannabinoids as medicine, U.S. Patent 6,630,507, while telling universities the plant was too dangerous to study in a teaching lab. Northern built the lab anyway. Whether CBD can take the edge off opioid craving, a separate and unfinished clinical question, is reported here. What the stalks and seed are good for, outside the flower trade entirely, is the subject of the industrial hemp piece. Michigan’s market, and the chemists it now has to employ, belong with U.S. news, science, and health reporting from The AEGIS Alliance.
